medigraphic.com
ISSN 1665-3254 (Print)
Revista Oficial de la Universidad Biomédica Rafael Guízar y Valencia A. C.

2005, Number 1-2

<< Back Next >>

Plasticidad y Restauración Neurológica 2005; 4 (1-2)

Contribution of the molecular genetics and of the magnetic resonance image to the knowledge of the neuroectodermic syndromes

Pascual-Castroviejo I, Taboada BJ, Aguilar-Rebolledo F

Language: Spanish
References: 43
Page: 82-97
PDF size: 264.28 Kb.


ABSTRACT

Between the neurocutaneous disorders a great majority has cutaneous expression as a plus sign of the disease, but their clinical and neuroradiological characteristics allow us to elaborate diagnoses criteria. In addition, genomic alterations of different chromosomes exist that give origin them and that will allow in a future a possible therapeutic approach. In this information the clinical characteristics, radiological and molecular are point out of the neurocutaneous syndromes more frequent.


REFERENCES

  1. National Institutes of Health Consensus Development Conference: Neurofibromatosis Conference Statement. Arch Neurol 1988; 45: 575-578.

  2. Walla MR, Marchuk DA, Andersen LE et al. Type 1 neurofibromatosis gene: Identification of a large transcript disrupt in three NF-1 patients. Science 1990; 249: 181-186.

  3. Yiskochil D, Euchberg AM; Xu 6 et al. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 1990; 62: 187-192.

  4. Cathon RM, Weiss R, Xu 6 et al. A major segment of the neurofibromatosis type 1 gene. cDNA sequence, genomic structure, and point mutations. Cell 1990; 62: 193-201.

  5. Ponder BAJ. Neurofibromatosis gene cloned. Nature 1990; 346: 703-704.

  6. Pascual-Castroviejo I. Trastornos neuroectodérmicos. En: 1. Pascual-Castroviejo (ed). El Libro del Año “Neurología”. 1992: 5-53.

  7. Pascual-Castroviejo I, Martínez Bermejo A, López Martín V, Roche C, Pascual-Pascual SI. Optic gliomas in neurofibromatosis type 1 (NF-1). Presentation of 31 cases. Neurologia 1994; 9: 173-177.

  8. Ledbetter DH, Rich DC, D’Connell P et al. Precise localization of NF1 to 17q11.2 by balanced translocation. Am Hum Genet 1989; 44: 20-24.

  9. Xu 6, O’Connell P, Viskochil D, et al. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 1990; 62: 599-608.

  10. Gutamn DH. Recent insights into neurofibromatosis type 1 clear genetic progress. Arch Neurol 1998; 55: 778-780.

  11. Easton DF, Ponder MA, Huson SM, Ponder BAJ. An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes. Am J Hum Genet 1993; 53: 305-313.

  12. Sadeh M, Martinovits G, Goldhammer Y. Occurrence of both neurofibromatosis 1 and 2 in the same individual with a rapidly progressive course. Neurology 1989; 39: 282-283.

  13. Wuerteleki W, Rouleau GA, Williams JP et al. Neurofibromatosis 2: clinical and DNA linkage studies of a large kindred. N Engl J Med 1988; 319: 278-283.

  14. Huson FM, Thrush DC. Central neurofibromatosis. Quart New Series 1985; 55: 213-224.

  15. Progress in Tuberous Sclerosis. Editorial. Lancet 1990; 336: 598-599.

  16. Pascual-Castroviejo I, Patrón M, Gutiérrez M, Carceller F, Pascual-Pascual SI. Tuberous sclerosis associated with histologically confirmed ocular and cerebral tumors. Pediatr Neurol 1995; 13: 172-174.

  17. Shepherd CW, Beard MC, Gomez MR, Kurland LT, WHisnat JP. Tuberous sclerosis complex in Olmstred County, 1950-1989. Arch Neurol 1991; 48: 400-401.

  18. Gomez MR. (ED). Tuberous sclerosis. 2nd Ed. New York. Raven Press 1988.

  19. Yamamoto N, Watanabe K, Negoro T, Matsumoto A, Miyazaki S et al. Long-term prognosis of tuberous sclerosis with epilepsy in children. Brain Dev 1987; 9: 292-295.

  20. Westmoreland BF. Electroencephalographic experience at the mayo clinic. In: Gomez MR (Ed). Tuberous Sclerosis. New York, Raven Press 1988: 37-49.

  21. Pascual-Castroviejo I, Roche C, Martínez-Bermejo A, Arcas J, López-Martín V, Tendero A, Esquiroz JLH, Pascual-Pascual SI. Hypomelanosis of Ito. A study of 76 infantile cases. Brian Dev 1998; 20: 36-41.

  22. Lungarotti MS, Martello C, Cabro A et al. Hypomelanosis of Ito associated with chromosomal translocation involving Xqll. Am Med Genet 1991; 40: 447-448.

  23. Pascual-Castroviejo I. Hipomelanosis de Ito. Alteraciones neurológicas en una serie de 48 casos. En: 1. Pascual-Castroviejo (ed): Trastornos Neuroectodérmicos. Barcelona. Prous, 1989: 127-137.

  24. Flannery DB. Pigmentary dysplasias, hypomelanosis of Ito and genetic mosaicism. Am Med Genet 1990; 35: 18-21.

  25. Urgellés E, Pascual-Castroviejo I, Roche C, Hernández-Moneo JL, Martínez MA, Vega A. Arteriovenous malformation in hypomelanosis of Ito. Brain Dev 1996; 18: 78-80.

  26. Sybert VP. Hypomelanosis of Ito: a description, not a diagnosis. J Invest Dermatol 1994; 103: 1415-1435.

  27. Hatchwell E. Hypomelanosis of Ito in and X; autosome translocations: a unifying hypothesis. J Med Genet 1996; 33: 177-183.

  28. Moss C, Larkins S, Stacy M, Blight A, Ferndon PA, Davison EV. Epidermal mosaicism and Blaschko’s lines. J Med Genet 1993; 30: 752-755.

  29. Pascual-Castroviejo I, Díaz-González C, García-Melian RM, González-Casado I, Muñoz Hiraldo E. Sturge-Weber syndrome: study of 40 patients. Pediatr Neurol 1993; 9: 283-288.

  30. Pascual-Castroviejo I, Pascual-Pascual SI, Viaño J, Martinez V, Coya J. Sturge-Weber syndrome without facial nevus. Neuropediatrics 1995; 26: 220-222.

  31. Pascual-Castroviejo I, López Martín V, Tendero A, Martínez Bermejo A, López-Terradas JM, Roche MC, Arcas J. Epidemiología y experiencia personal de los trastornos neuroectodérmicos. Barcelona JR Prous 1989: 1-71.

  32. Noriega-Sanchez A, Marc Ant ON, Herdon JH,. Oculocutaneous Melanosis, associate with Sturge-Weber syndrome. Neurology 1972; 22: 256-262.

  33. Von Hippel Landau Disease editorial. Lancet 1991; 337: 1065.

  34. Newmann HPH, Wiestler OD. Clustering of features of Von Hippel Landau syndrome: Evidence for a complex genetic locus. Lancet 1991; 337: 1052-1054.

  35. Latif F, Tory K, Gnarra J, Yao M, Duch FM, Orcutt ML et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993; 260: 1317-1320.

  36. Garrod AE. Peculiar pigmentation of the skin in a infant. Trans Clin Soc Lon 1906; 39: 217-217.

  37. Avrahami E, Harel S, Hurgenson U, Cohn DF. Computed tomography demonstration of brain changes in incontinentia pigmenti. AJDC 1985; 139: 372-374.

  38. Shuper A, Briant RN, Singer HS. Destructive encephalopathy in incontinentia pigmenti. A primary disorder? Pediatric Neurol 1990; 6: 137-140.

  39. Goh WHS, Lo R. A new syndrome: cerebellar hypoplasia, cavernous hemangioma and coarctation of the aorta. Dev Med Child Neurol 1993; 35: 637-641.

  40. Pascual-Castroviejo I, Viaño J, Pascual-Pascual SI, Martínez V. Facial hemangioma, agenesis of the internal carotid artery and cerebral cortex dysplasia: case report. Neuroradiology 1995; 37: 692-695.

  41. Pascual Castroviejo I, Viaño J, Pascual-Pascual SI, Martines V. Malformaciones Vasculares Congénitas en la Infancia. Rev Neurol 1999; 29: 217-230.

  42. Pascual-Castroviejo I, Viaño J, Moreno F, Palencia R, Martínez Fernández V, Pascual-Pascual SI et al. Hemangiomas of the head, neck and chest with associated vascular and brain anomalies: A complex neurocutaneous syndrome. Am J Neuroradiol 1996; 17: 461-471.

  43. Pascual-Castroviejo I, Veles A, Pascual-Pascual SI, Roche MC, Villarejo R. Dandy-Walker malformation: Analysis of 38 cases. Child’s Nervous System 1991; 7: 88-97.




2020     |     www.medigraphic.com